David Porter - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock David Porter’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Hospitals,
- Wellness,
- Investment Management,
- Healthcare Innovation,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Automation,
- Software,
- Manufacturing,
- Biotechnology,
- Medical Devices,
- Cosmetics,
- Genomics,
- Neuroscience,
- Digital Transformation,
- Consulting,
- Hardware,
- Telehealth,
- Medical Diagnostics,
- Health Diagnostics,
- Social Impact,
- UK-based Startups,
- Digital Health,
- Medical,
- Information Technology,
- B2B,
- Therapeutics,
- Molecular Diagnostics,
- Media and Entertainment,
- Pharmaceuticals,
- Acquisitions,
- Biometrics
Social media:
Past investments:
- Convergence Pharmaceuticals
- 1MED SA (Apposite Capital Investment)
- Ulthera, Inc (Apposite Capital Investment)
- ZONARE Medical Systems, Inc. (Apposite Capital Investment)
- Ulthera
- Serentis
- NIMGenetics
- MC Care (Apposite Capital Investment)
- Medical Imaging Partnership
- Ambit Biosciences
- NIMGenetics (Apposite Capital Investment)
- Habitus (Apposite Capital Investment)
- CrestOptics (Apposite Capital Investment)
- CancerPartnersUK (Apposite Capital Investment)
- PharmaKodex
- Bird Rock Bio
- Mirada Medical
- Cancer Partners UK
- Ambrx
- Swanton Care & Community (Apposite Capital Investment)
- Anaphore
Investor Profile
David Porter is a Venture Capital, Private Equity Firm based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Convergence Pharmaceuticals, 1MED SA (Apposite Capital Investment), Ulthera, Inc (Apposite Capital Investment), ZONARE Medical Systems, Inc. (Apposite Capital Investment), Ulthera, Serentis, NIMGenetics, MC Care (Apposite Capital Investment), Medical Imaging Partnership, Ambit Biosciences, NIMGenetics (Apposite Capital Investment), Habitus (Apposite Capital Investment), CrestOptics (Apposite Capital Investment), CancerPartnersUK (Apposite Capital Investment), PharmaKodex, Bird Rock BioMirada Medical, Cancer Partners UK, Ambrx, Swanton Care & Community (Apposite Capital Investment), Anaphore, . Over time, David Porter has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether David Porter is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Investment Management, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Automation, Software, Manufacturing, Biotechnology, Medical Devices, Cosmetics, Genomics, Neuroscience, Digital Transformation, Consulting, Hardware, Telehealth, Medical Diagnostics, Health Diagnostics, Social Impact, UK-based Startups, Digital Health, Medical, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Pharmaceuticals, Acquisitions, Biometrics may find it worthwhile to explore potential connections with David Porter, as their portfolio suggests a familiarity and interest in this area.
Understanding David Porter’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
